Collectively, our findings illuminate a previously undescribed post-translation mechanism in which AMPK activity is regulated by E3 ubiquitin ligase and provides an attractive therapeutic strategy for the treatment of obesity and its related comorbidities. Here, PRKAA1 is linked to obesity disorder.